Skip to Main Content

Author Details

Jaclyn LoPiccolo
Dana-Farber Cancer Institute
2007
23
15
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36711812Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients.Res Sq2023
37550415Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary.Nat Med2023
37384867Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in <i>BRD4-NUTM1</i> NUT Carcinoma Harboring a <i>BRD4</i> Splice Site Mutation.JCO Precis Oncol2023
33402459Combining Nelfinavir With Chloroquine Inhibits <i>In Vivo</i> Growth of Human Lung Cancer Xenograft Tumors.In Vivo2021
30820976Reply.Hepatology2019
31287031Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series.J Immunother Cancer2019
30398560Further Lessons in Pneumocystis Pneumonia Prophylaxis-Reply.JAMA Intern Med2018
29913012Corticosteroid Use and Pneumocystis Pneumonia Prophylaxis: A Teachable Moment.JAMA Intern Med2018
30014512Nodular Regenerative Hyperplasia Associated With Immune Checkpoint Blockade.Hepatology2018
29046393Rac1-stimulated macropinocytosis enhances Gβγ activation of PI3Kβ.Biochem J2017
25800850Identification of the Rab5 binding site in p110β: assays for PI3Kβ binding to Rab5.Methods Mol Biol2015
26475863Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α Homodimer.J Biol Chem2015
26173259Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity.Biochem J2015
25327558A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors.Oncotarget2014
22825471Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells.Cell Death Dis2012
22764099Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine.Cell Death Dis2012
19330036A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis.PLoS One2009
18166498Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.Drug Resist Updat2008
18000394Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy.Autophagy2008
17097759Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma.Lung Cancer2007
17667591Targeting Akt in cancer therapy.Anticancer Drugs2007
17785575Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo.Clin Cancer Res2007
17643312PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development.Crit Rev Oncol Hematol2007
  • 1 - 23 of 23

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 1
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Xi Liu
College of Biology and Food, Shangqiu Normal University
Career Start Year 2007
Number of shared co-authors 0
Julia Carnevale
University of California san francisco
Career Start Year 2006
Number of shared co-authors 0
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Shubham Pant
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 0
Kenneth D Westover
University of Texas Southwestern Medical Center
Career Start Year 1998
Number of shared co-authors 1
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 1
Changchun Deng
Center for Lymphoid Malignancies, Columbia University Medical Center
Career Start Year 1997
Number of shared co-authors 0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 2
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 0
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 1
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 1
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 5
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 4
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Thomas John
Peter MacCallum Cancer Centre
Career Start Year 1973
Number of shared co-authors 1

Collaborators

Anne R Bresnick
Albert Einstein College of Medicine
Co-authored papers 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Jonathan M Backer
Albert Einstein College of Medicine
Co-authored papers 3
Michael Brenowitz
Albert Einstein College of Medicine
Co-authored papers 2
Sylvan C Baca
Co-authored papers 2
Deborah Schrag
Memorial-Sloan Kettering Cancer Center
Co-authored papers 2
Gideon M Blumenthal
Oncology Center of Excellence
Co-authored papers 2
Patricia S Steeg
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Bin Wu
University of Pennsylvania
Co-authored papers 1
Robert H Shoemaker
National Cancer Institute
Co-authored papers 1
Pasi A J??nne
Dana-Farber Cancer Institute
Co-authored papers 1
Brian T Chait
The Rockefeller University
Co-authored papers 1
David J Liewehr
Center for Cancer Research
Co-authored papers 1
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Seung Joong Kim
Korea Advanced Institute of Science and Technology (KAIST)
Co-authored papers 1
Haiyan Wu
First Affiliated Hospital, Sun Yat-sen University
Co-authored papers 1
Robert H Singer
Albert Einstein College of Medicine
Co-authored papers 1
Yi Shi
College of Medicine, Yangzhou University
Co-authored papers 1
Release 1.2